A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity data. (2019)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.35340
Publication URI: https://www.repository.cam.ac.uk/handle/1810/288021
Type: Journal Article/Review